PharmacoEconomics, 1170-7690

Journal

Publications

  1. Article › Research › Not peer-reviewed
  2. Published

    A fair innings for NICE?

    Nick Freemantle & Joanne Eastaugh, 1 Jan 2002, In: PharmacoEconomics. 20, 6, p. 389-391 3 p.

    Research output: Contribution to journalArticle

  3. Published

    A role of two-stage pharmacoeconomic appraisal?

    Nick Freemantle, 1 Jan 2003, In: PharmacoEconomics. 21, p. 761-767 7 p.

    Research output: Contribution to journalArticle

  4. Published

    Cost Effective Strategies in the Prevention of Diabetic Nephropathy

    Jonathan Rippin, Tony Barnett & Stephen Bain, 1 Jan 2004, In: PharmacoEconomics. 22, p. 9-28 20 p.

    Research output: Contribution to journalArticle

  5. Published
  6. Published
  7. Published

    Developing revised NICE Appraisal Technical Guidance to Manufacturers and Sponsors: opportunity or threat?

    Rodney Taylor, 1 Jan 2002, In: PharmacoEconomics. 20, 15, p. 1031-1038 8 p.

    Research output: Contribution to journalArticle

  8. Published

    How much is the cost of blindness? Caveat Emptor

    Catherine Meads & Christopher Hyde, 1 Jan 2006, In: PharmacoEconomics. 24, 2, p. 207-209 3 p.

    Research output: Contribution to journalArticle

  9. Published
  10. Published

    New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?

    Gregory Lip, 1 Jan 2009, In: PharmacoEconomics. 27, 10, p. 793-5 3 p.

    Research output: Contribution to journalArticle

  11. Published

    Real world trials to answer real world questions

    Nick Freemantle, Richard Hobbs, 1 Jan 2005, In: PharmacoEconomics. 23, p. 747-754 8 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 Next